Hormone Deficiencies News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

News Bell: TherapeuticsMD, Inc. (NYSE:TXMD), Urban Outfitters Inc. (NASDAQ:URBN) - The Oracle Examiner



News Bell: TherapeuticsMD, Inc. (NYSE:TXMD), Urban Outfitters Inc. (NASDAQ:URBN) 
The Oracle Examiner
The stock currently has a Market Capitalization of 1.34 Billion. TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It ...

and more » 


Antidiuretic Hormone Vasopressin Stabilizes Blood Volume, Study Shows - Sci-News.com



Sci-News.com
 
Antidiuretic Hormone Vasopressin Stabilizes Blood Volume, Study Shows 
Sci-News.com
In mouse models, they showed that vasopressin boosted red blood cell formation faster than the other well-characterized hormone, erythropoietin. The team narrowed in on this unexpected role for vasopressin by examining clinical data from 92 patients ...

 


Looking back at the career of a Stanford pediatrician - Scope (blog)



Scope (blog)
 
Looking back at the career of a Stanford pediatrician 
Scope (blog)
Half a century ago, a doctor who built a long career taking care of children with hormone deficiencies was just getting his scientific start. In a brief column appearing online this week, ?50 years ago in The Journal of Pediatrics,? three Stanford ...

 


FY2018 Earnings Forecast for TherapeuticsMD, Inc. Issued By Jefferies Group (TXMD) - Dispatch Tribunal



FY2018 Earnings Forecast for TherapeuticsMD, Inc. Issued By Jefferies Group (TXMD) 
Dispatch Tribunal
TherapeuticsMD, Inc is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone ...

and more » 


DARA Biosciences (DARA) & TherapeuticsMD (TXMD) Financial Comparison - The Ledger Gazette



TrueBlueTribune
 
DARA Biosciences (DARA) & TherapeuticsMD (TXMD) Financial Comparison 
The Ledger Gazette
TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone ...
Deutsche Bank Analysts Give TherapeuticsMD (TXMD) a $9.00 ... Week Herald

all 23 news articles » 


Deepening the nature v. nurture debate: How hormones impact development in the womb is often most key - Genetic Literacy Project



Genetic Literacy Project
 
Deepening the nature v. nurture debate: How hormones impact development in the womb is often most key 
Genetic Literacy Project
And there is now research suggesting a third manner of passing on genetics to offspring: the control of genetic expression and hormonal imprinting set in motion by exposure to hormones during gestation. The research in this arena is ongoing, but it is ...

 


TherapeuticsMD (TXMD) Cut to Sell at Zacks Investment Research - The Ledger Gazette



TherapeuticsMD (TXMD) Cut to Sell at Zacks Investment Research 
The Ledger Gazette
TherapeuticsMD, Inc is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone ...

and more » 


TherapeuticsMD (TXMD) Given Buy Rating at Cantor Fitzgerald - TrueBlueTribune



TherapeuticsMD (TXMD) Given Buy Rating at Cantor Fitzgerald 
TrueBlueTribune
TherapeuticsMD, Inc is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone ...
Zacks Investment Research Downgrades TherapeuticsMD Inc ... BangaloreWeekly
GSA Capital Partners LLP Purchases New Holdings in ... StockNewsTimes
TherapeuticsMD (NASDAQ:TXMD) Downgraded by BidaskClub to ... Week Herald

all 11 news articles » 


Start 2018 with a Company That's Changing the Face of Aging in ... - Markets Insider



Start 2018 with a Company That's Changing the Face of Aging in ... 
Markets Insider
LOS ANGELES, Jan. 11, 2018 /PRNewswire/ -- "This is the best thing that's happened to me!" states Angie Sadeghi, M.D., the Supervising Physician at Beverly Hills Rejuvenation Center in Newport Beach (www.BHRCenter.com), and she can't say enough about ...

and more » 


TherapeuticsMD, Inc. (NASDAQ:TXMD) Forecasted to Earn FY2018 Earnings of ($0.40) Per Share - The Ledger Gazette



TherapeuticsMD, Inc. (NASDAQ:TXMD) Forecasted to Earn FY2018 Earnings of ($0.40) Per Share 
The Ledger Gazette
TherapeuticsMD, Inc is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone ...
FY2018 EPS Estimates for TherapeuticsMD, Inc. Lowered by Analyst ... Dispatch Tribunal
TherapeuticsMD (NASDAQ:TXMD) Rating Reiterated by Noble ... Week Herald

all 10 news articles »